EurekAlert -- Nearly two-thirds of children who undergo routine interventional cardiology procedures -- those involving a catheter to treat structural disorders of the heart -- may be receiving treatment with a device that’s being used for an off-label application. This finding underscores the need for the appropriate agencies to include pediatric applications when reviewing and approving cardiac device processes in the United States, according to Robert Beekman, MD, a pediatric cardiologist at the Heart Institute, Cincinnati Children’s Hospital Medical Center.
